The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers, biochemists, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration. Join 23+ expert […]

As Europe’s premiere microbiome conference tightly focused on the development of microbiome-based therapeutics, this is your prime opportunity to expand your microbiome-based drug development capabilities and business potential as we aim to deliver clinical results and ensure therapeutic microbiome approval in Europe. No matter what stage of development you're focusing on, this is your one-stop […]

As we witness a surge in later-stage clinical trials within the gene therapy industry, the spotlight on comparability has never been brighter. That's why we're thrilled to announce the return of the 4th Gene Therapy Comparability Summit, taking place in Boston, MA, February 13-15. This event is your gateway to uncovering how to implement effective comparability […]

100+ Technical mRNA Specialists | 35+ Expert Speakers As access to faster and higher-throughput analytical methods becomes increasingly vital, it is critical that we employ superior analytical approaches for mRNA-based therapeutics and vaccines to ensure high quality and effective drugs are approved, whilst adhering to regulatory guidelines. The 3rd mRNA Analytical Development Summit returns to Boston in February to […]

The 6th Annual CRISPR AgBio Congress is back on February 20-22, 2024 (Raleigh, NC). The dedicated congress that unites industry stakeholders across Agbiotech, big seed, distributors, and investors, to assess this new regulatory terrain, examine recent scientific breakthroughs, and strategize the journey of CRISPR products from editing to delivery, field to shelf. Discover the full […]

Viral Vector Process Development & Manufacturing Summit Create Qualitative, Accessible Treatments for Patients Following Ring Therapeutics’ injection of $86.5m to enhance novel viral vector capabilities, and BMS’s viral vector facility coming online, the viral vector market is forecasted to reach $12.8bn – not only in cell and gene therapies but also viral-vector-based vaccines and immunotherapies. […]

From Bristol Myers Squibb expanding their cardiovascular partnership with Avidity Biosciences' antibody-oligonucleotide conjugate technology, to Nurix and Seagen collaborating on a targeted protein degradation conjugate, there is now a staggering amount of investment and collaboration in the novel conjugates space. As highlighted above, drug developers are pushing the boundaries of traditional ADCs by designing and developing novel targeting formats and payloads. Whilst the likes of VincerX Pharma, Dyne Therapeuitcs and Alnylam are now […]

The Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Actively engage with the likes of Merck, Pfizer, SNIPR Biome, Locus Biosciences, Phiogen, AMR Action Fund and 90+ phage experts to demonstrate positive clinical data and patient outcomes. Take advantage of this unique opportunity to be a part of the dialogue, […]

Cell therapy continues to transform the oncology field, and this year has also seen the translation of cell therapies’ curative potential into the autoimmune space. Providing your team with exclusive access to cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe is your must-attend forum to stay at the forefront of these innovations.   300+ […]